SUPERFICIAL SPREADING MELANOMA STAGE I

SUPERFICIAL SPREADING MELANOMA STAGE I was reported 36 times

SUPERFICIAL SPREADING MELANOMA STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Melanocortin 4 Receptor Agonist [EPC] 1 0.0035
1 Thiazide-like Diuretic [EPC] 2 0.0000
2 Recombinant Human Growth Hormone [EPC] 1 0.0000
3 Ester Local Anesthetic [EPC] 2 0.0000
4 Androgen [EPC] 1 0.0000
5 Angiotensin 2 Receptor Blocker [EPC] 11 0.0000
6 Thiazide Diuretic [EPC] 6 0.0000
7 Dihydropyridine Calcium Channel Blocker [EPC] 9 0.0000
8 Interleukin-17A Antagonist [EPC] 1 0.0000
9 Non-Standardized Chemical Allergen [EPC] 2 0.0000
10 Amide Local Anesthetic [EPC] 2 0.0000
11 Antiarrhythmic [EPC] 2 0.0000
12 Thalidomide Analog [EPC] 8 0.0000
13 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
14 Integrin Receptor Antagonist [EPC] 1 0.0000
15 Interferon beta [EPC] 2 0.0000
16 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
17 Purine Antimetabolite [EPC] 1 0.0000
18 Aminosalicylate [EPC] 1 0.0000
19 Proteasome Inhibitor [EPC] 1 0.0000
20 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
21 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
22 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
23 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
24 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
25 Microtubule Inhibitor [EPC] 1 0.0000
26 Corticosteroid [EPC] 6 0.0000
27 Alkylating Drug [EPC] 1 0.0000
28 Factor Xa Inhibitor [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 2 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
31 GLP-1 Receptor Agonist [EPC] 1 0.0000
32 Insulin Analog [EPC] 1 0.0000
33 Proton Pump Inhibitor [EPC] 1 0.0000
34 Benzodiazepine [EPC] 1 0.0000